Product Information
AIMOVIG 140 MG/ML AUTOINJECTOR is a brand product labeled by Amgen Inc., priced at $753.6695 per ML under NDC 55513084301. Its NADAC has been published 367 times since Jun 19, 2019.
Strength
140 mg/mL
Manufacturer
Amgen Inc.NDC
55513084301
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
ERENUMABApproval Type
Biologic (BLA)
FDA Application
BLA761077On Market Since
3/15/2019
Price Statistics
The NADAC for AIMOVIG 140 MG/ML AUTOINJECTOR has been published 367 times since Jun 19, 2019, and over the history we have for it it has risen 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $753.6695 per ML |
|---|---|
| All-time high | $753.9416 (May 13, 2026) |
| All-time low | $554.3750 (Jun 19, 2019) |
| 52-week high | $753.9416 |
| 52-week low | $739.0576 |
| Median price | $675.0571 |
| Average price | $668.7707 |
| Largest weekly change | +5.9% (Feb 2, 2022) |
| Weeks tracked | 367 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the erenumab-aooe market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AIMOVIG 140 MG/ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for AIMOVIG 140 MG/ML AUTOINJECTOR, manufactured by Amgen Inc., is $753.6695 per ML (NDC 55513084301), effective Jun 24, 2026.
How has the price of AIMOVIG 140 MG/ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for AIMOVIG 140 MG/ML AUTOINJECTOR has risen 35.9%. It has been tracked across 367 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for AIMOVIG 140 MG/ML AUTOINJECTOR?
Since Jun 19, 2019, the NADAC for AIMOVIG 140 MG/ML AUTOINJECTOR has ranged from a low of $554.3750 (Jun 19, 2019) to a high of $753.9416 (May 13, 2026), with a median of $675.0571 per ML.
Are there cheaper alternatives to AIMOVIG 140 MG/ML AUTOINJECTOR?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AIMOVIG 140 MG/ML AUTOINJECTOR, so no direct lower-cost alternative is listed.
Who manufactures AIMOVIG 140 MG/ML AUTOINJECTOR?
AIMOVIG 140 MG/ML AUTOINJECTOR (NDC 55513084301) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification